NEXTURNBIOSCIENCE Co., Ltd. (KOSDAQ:089140)
2,770.00
+65.00 (2.40%)
Last updated: May 12, 2025
NEXTURNBIOSCIENCE Revenue
In the year 2024, NEXTURNBIOSCIENCE had annual revenue of 31.64B KRW, down -23.31%. NEXTURNBIOSCIENCE had revenue of 7.63B in the quarter ending December 31, 2024, a decrease of -35.61%.
Revenue
31.64B
Revenue Growth
-23.31%
P/S Ratio
1.14
Revenue / Employee
555.09M
Employees
57
Market Cap
35.99B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 31.64B | -9.62B | -23.31% |
Dec 31, 2023 | 41.26B | 17.79B | 75.84% |
Dec 31, 2022 | 23.46B | 6.49B | 38.24% |
Dec 31, 2021 | 16.97B | 7.29B | 75.24% |
Dec 31, 2020 | 9.69B | -15.43B | -61.43% |
Dec 31, 2010 | Pro | Pro | Pro |
Dec 31, 2009 | Pro | Pro | Pro |
Dec 31, 2008 | Pro | Pro | Pro |
Dec 31, 2007 | Pro | Pro | Pro |
Dec 31, 2006 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Electronics | 308.07T |
SK hynix | 71.40T |
LG Energy Solution | 25.76T |
Samsung Biologics | 4,547.32B |
Hyundai Motor Company | 178.98T |
Hanwha Aerospace | 11.24T |
Kia Corporation | 107.45T |
HD Hyundai Heavy Industries | 14.49T |